Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 125

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 125
---
 we do not file financial statements on a timely basis as required by the SEC, we could face severe consequences. If we are unable
to conclude that its internal control over financial reporting is effective, investors may lose confidence in the accuracy and completeness
of our financial reports, the market price of our Common Stock could decline, and we could be subject to sanctions or investigations
by the Nasdaq, the SEC or other regulatory authorities. Moreover, responding to such investigations, are likely to consume a significant
amount of our management resources and cause us to incur significant legal and accounting expenses. Failure to remedy any material weakness
in internal control over financial reporting, or to maintain effective control systems, could also restrict our future access to the
capital markets. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of
our financial statements.

<div align='center'>65</div>

As a public reporting company, we are subject to filing deadlines for reports that we file pursuant to the Exchange Act, and our failure to timely file such reports may have material adverse consequences on our business.

Following the consummation
of the Business Combination, we failed to timely file our Form 8-K with Form 10 information prior to the “staleness” date
(as determined in accordance with the applicable rules and regulations of the SEC) applicable to the financial statements that were required
by the applicable accounting requirements and other rules and regulations of the SEC to be included in such filing (including pro forma
financial information); thus, we have not remained current in our reporting requirements with the SEC since we became an SEC reporting
company on February 14, 2024. Although we have since regained status as a current filer by filing a Form 8-K/A with current financial
statements on April 1, 2024, we will not be eligible to use a registration statement on Form S-3 that would allow us to continuously
incorporate by reference our SEC reports into the registration statement, or to use “shelf” registration statements to conduct
offerings, until approximately one year from the date we regained (and maintain) status as a current filer. Until such time, if we determine
to pursue an offering, we would be required to conduct the offering on an exempt basis, such as in accordance with Rule 144A, or file
a registration statement on Form S-1. Using a Form S-1 registration statement for a public offering would likely take significantly longer
than using a